These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1407404)

  • 1. Blockade of dopamine autoreceptors by haloperidol and the apparent dynamics of potassium-stimulated endogenous release of dopamine from and reuptake into striatal suspensions in the rat.
    McElvain JS; Schenk JO
    Neuropharmacology; 1992 Jul; 31(7):649-59. PubMed ID: 1407404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
    Joseph JA; Dalton TK; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
    Umeda Y; Sumi T
    Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
    Kihara T; Ikeda M; Matsushita A
    Brain Res; 1990 Jun; 519(1-2):44-9. PubMed ID: 2397417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in dopamine metabolism after chronic administration of haloperidol. Possible role of increased autoreceptor sensitivity.
    Saller CF; Salama AI
    Neuropharmacology; 1985 Feb; 24(2):123-9. PubMed ID: 3990917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic systemic administration of some typical antipsychotic drugs on turnover of dopamine and potassium ion-induced release of dopamine in the striatum of the rat in vivo.
    Patterson TA; Schenk JO
    Neuropharmacology; 1991 Sep; 30(9):943-52. PubMed ID: 1922694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
    Rothblat DS; Schneider JS
    Neurosci Lett; 1997 Jun; 228(2):119-22. PubMed ID: 9209113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A further evaluation of the effects of K+ depolarization on glutamate-evoked [3H]dopamine release from striatal slices.
    Bowyer JF; Newport GD; Lipe GW; Frame LT
    J Pharmacol Exp Ther; 1992 Apr; 261(1):72-80. PubMed ID: 1348539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats.
    Hillegaart V; Ahlenius S; Fowler CJ; Magnusson O
    Pharmacol Toxicol; 1988 Aug; 63(2):114-7. PubMed ID: 3186617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declines in stimulated striatal dopamine release over the first 32 h following microdialysis probe insertion: generalization across releasing mechanisms.
    Holson RR; Gazzara RA; Gough B
    Brain Res; 1998 Oct; 808(2):182-9. PubMed ID: 9767162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum.
    Kawagoe KT; Garris PA; Wiedemann DJ; Wightman RM
    Neuroscience; 1992 Nov; 51(1):55-64. PubMed ID: 1465186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the cholinergic system in haloperidol-induced release of dopamine from slices of striatum in the rat.
    Yamada S; Nishi S; Kojima H; Yokoo H; Tsutsumi T; Inanaga K
    Neuropharmacology; 1990 Jan; 29(1):55-9. PubMed ID: 2304616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.